Metabolic syndrome components and vitamin D availability relationship in late postmenopausal women

BACKGROUND: The global prevalence of vitamin D deficiency is currently a real threat due to association with major chronic non-communicable diseases. Abdominal obesity, hypertension, dyslipidemia, and hyperglycemia contribute significantly to cardiometabolic risk in late postmenopausal women.

AIM: to assess the frequency of deficiency and insufficiency of 25(OH)D in late postmenopausal residents of Yekaterinburg; to establish associations of 25(OH)D serum concentration with components of metabolic syndrome and severity of menopausal symptoms.

MATERIALS AND METHODS: During the period from October 2018 to March 2020 145 independently living late postmenopausal residents of Yekaterinburg were enrolled in a cross-sectional study. The following scope of data regarding each of the subjects was collected: complaints and anamnesis, anthropometry, diagnosis of metabolic syndrome, arterial hypertension and diabetes mellitus, assessment of 25 (OH)D level by the ECLIA method, LDL-C, HDL-C levels, serum TG by the enzymatic colorimetric method, as well as the evaluation of the modified menopausal index.

RESULTS: Adequate serum level of 25(OH)D was detected in 20.6% patients, insufficiency and deficiency were found in 33.1 and 46.2% cases, respectively. In patients with vitamin D deficiency and insufficiency, the most frequent metabolic syndrome components were arterial hypertension (p=0.02; OR 3.5; CI 1.2–10.6) and abdominal obesity (p=0.03; OR 2.8; CI 1.1–7.2). Vitamin D deficient subjects had significantly lower serum HDL and increased TG levels (p=0.04), compared to the adequately provided 25(OH)D patients. Vitamin D levels were not associated with the severity of menopausal symptoms in late postmenopausal women. Regular daily intake of 400–2000 IU of colecalciferol contributed to higher serum 25(OH)D level.

CONCLUSION: a high prevalence of vitamin D deficiency among postmenopausal women of Yekaterinburg was detected. Diagnosis and correction of vitamin D levels are necessary for timely reduction of cardiometabolic risk, primarily due to the potential pleiotropic effects of D-hormone on the renin-angiotensin-aldosterone system, carbohydrate and lipid metabolism.

1. Hilger J, Friedel A, Herr R, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr. 2014;111(1):23-45. doi: https://doi.org/10.1017/S0007114513001840

2. de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, et al. Vitamin D and cardiovascular health. Clin Nutr. 2021;40(5):2946-2957. doi: https://doi.org/10.1016/j.clnu.2020.12.025

3. Schmitt EB, Nahas-Neto J, Bueloni-Dias F, et al. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women. Maturitas. 2018;107(5):97-102. doi: https://doi.org/10.1016/j.maturitas.2017.10.011

4. Nimitphong H, Park E, Lee MJ. Vitamin D regulation of adipogenesis and adipose tissue functions. Nutr Res Pract. 2020;14(6):553-567. doi: https://doi.org/10.4162/nrp.2020.14.6.553

5. Grineva EN, Karonova T, Micheeva E, et al. Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age. Aging (Albany NY). 2013;5(7):575-581. doi: https://doi.org/10.18632/aging.100582

6. Szymczak-Pajor I, Drzewoski J, Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020;21(18):6644 doi: https://doi.org/10.3390/ijms21186644

7. Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol. 2013;5(1):51-108. doi: https://doi.org/10.4161/derm.24494

8. Pigarova EA, Rozhinskaya LY, Belaya JE, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84. (In Russ.) doi: https://doi.org/10.14341/probl201662460-84

9. Karonova TL, Grinyova EN, Nikitina IL, et al. The prevalence of vitamin D deficiency in the northwestern region of the Russian Federation among the residents of St. Petersburg and Petrozavodsk. Osteoporosis and Bone Diseases. 2013;16(3):3-7. (In Russ.) doi: https://doi.org/10.14341/osteo201333-7

10. Shalina MA. Metabolic syndrome in older women. J Obstet women’s Dis. 2019;68(3):81-88. (In Russ.). doi: https://doi.org/10.17816/JOWD68381-88

11. Butrova SA, Berkovskaja MA, Dzgoeva FH, Komshilova KA. Rasprostranennost’ ozhirenija, kardiometabolicheskih faktorov riska, metabolicheskogo sindroma i saharnogo diabeta sredi zhenshhin razlichnyh vozrastnyh grupp Moskovskogo regiona Obesity and metabolism. 2009;6(4):28-33. (In Russ.). doi: https://doi.org/10.14341/2071-8713-4875

12. Sukhikh GT, Smetnik VP, Andreeva EN, et al. Menopauzal’naya gormonoterapiya i sokhranenie zdorov’ya zhenshchin v zrelom vozraste. Klinicheskie rekomendatsii (protokol lecheniya). Moscow, 2016. (In Russ.).

13. World Health Organization [Internet]. Obesity: preventing and managing the global epidemic. 1997. Geneva: WHO [cited 25.04.2023]. Available from: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/

14. Ministerstvo zdravoohranenija RF. Rekomendatsii po vedeniyu bol’nykh s metabolicheskim sindromom. Klinicheskie rekomendatsii. Moscow; 2013. (In Russ.) Доступно по: http://www.gipertonik.ru/files/recommendation/Recommendations_metabolic_syndrome.doc Ссылка активна на 22.03.2021

15. Kobalava ZhD, Konradi AO, Nedogoda SV, et al.; Russian society of cardiology. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):37-86 (In Russ.). doi: https://doi.org/10.15829/1560-4071-2020-3-3786.

16. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2019;22(S1):1-144 (In Russ.). doi: https://doi.org/10.14341/DM221S1

17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. doi: https://doi.org/10.1093/clinchem/18.6.499

18. Smetnik VP., Tkachenko NM., Glezer GA., Moskalenko NP. Klimaktericheskij sindrom. Moscow: Medicina; 1988. (In Russ.).

19. Suplotova LA, Avdeeva VA, Rozhinskaya LY. Vitamin D status in residents of Tyumen region. Obesity and metabolism. 2019;16(2):69-74. (In Russ.). doi: https://doi.org/10.14341/omet10162

20. Shvarc GJa. Vitamin D i D-gormon. Moscow: Anacharsis; 2005. (In Russ.).

21. Bahtijarova SA, Lesnjak OM, Paul L, Kuznecova NL. Rasprostranennost’ deficita vitamina D u pozhilyh ljudej goroda Ekaterinburga. Nauchno-prakticheskaja revmatologija. 2004;42(2):219. (In Russ.).

22. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4):1536-1538. doi: https://doi.org/10.1172/JCI112134

23. Need AG, Morris HA, Horowitz M, Nordin C. Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr. 1993;58(6):882-885. doi: https://doi.org/10.1093/ajcn/58.6.882

24. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity [published correction appears in Am J Clin Nutr. 2003;77(5):1342]. Am J Clin Nutr. 2000;72(3):690-693. doi: https://doi.org/10.1093/ajcn/72.3.690

25. Tsuji K, Maeda T, Kawane T, et al. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J Bone Miner Res. 2010;25(8):1711-1723. doi: https://doi.org/10.1002/jbmr.65

26. Elkhwanky MS, Kummu O, Piltonen TT, et al. Obesity Represses CYP2R1, the Vitamin D 25-Hydroxylase, in the Liver and Extrahepatic Tissues. JBMR Plus. 2020;4(11):e10397. doi: https://doi.org/10.1002/jbm4.10397

27. McGill A-T, Stewart JM, Lithander FE, et al. Relationships of low serum vitamin D3with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008;7(1):4. doi: https://doi.org/10.1186/1475-2891-7-4

28. Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D supplementation on serum 25OHD in thin and obese women. J Steroid Biochem Mol Biol. 2013;(136):195-200. doi: https://doi.org/10.1016/j.jsbmb.2012.12.003

29. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010;59(1):242-248. doi: https://doi.org/10.2337/db09-1011

30. Chacko SA, Song Y, Manson JE, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr. 2011;94(1):209-217. doi: https://doi.org/10.3945/ajcn.110.010272

31.